Chlamydia trachomatis is an important human pathogen. Research to develop a Chlamydia vaccine has focused on the major outer membrane protein (MOMP). Determinants of this protein elicit serovar-specific neutralizing antibodies which are thought to play a critical role in protective immunity. MOMP-specific antibody responses are highly variable in the polymorphic population. Genetic factors which might influence the MOMP-specific immune response are consequently of particular interest. The C. psittaci strain guinea pig inclusion conjunctivitis (GPIC) is a natural pathogen of the guinea pig that causes both ocular and genital tract infections that closely resemble those caused by C. trachomatis in humans. As such, it provides an excellent model for disease. In this report, we explore the influence of major histocompatibility complex-linked genes on the MOMP-specific antibody response in mice immunized with either whole GPIC elementary bodies or recombinant GPIC MOMP. Our results indicate that the MOMP-specific antibody response is major histocompatibility complex linked such that mice of the H-2d haplotype are high responders while mice of the H-2 haplotype are low responders. We demonstrate that MOMP-specific B cells are present in H-2k strains which are, however, deficient in MOMP-specific helper T cells. Although immunization of low-MOMPresponder strains with whole chlamydial elementary bodies induces high levels of immunoglobulin G antibody specific for Omp2, the cysteine-rich outer membrane protein, MOMP-specific B cells are unable to receive help from Omp2-specific T cells. The failure of intermolecular help from Omp2-specific T cells and related observations raise important issues regarding the processing and presentation of chlamydial antigens and the design of optimal subunit vaccines.
Chlamydia trachomatis is an important human pathogen. Research to develop a Chlamydia vaccine has focused on the major outer membrane protein (MOMP). Determinants of this protein elicit serovar-specific neutralizing antibodies which are thought to play a critical role in protective immunity. MOMP-specific antibody responses are highly variable in the polymorphic population. Genetic factors which might influence the MOMP-specific immune response are consequently of particular interest. The C. psittaci strain guinea pig inclusion conjunctivitis (GPIC) is a natural pathogen of the guinea pig that causes both ocular and genital tract infections that closely resemble those caused by C. trachomatis in humans. As such, it provides an excellent model for disease. In this report, we explore the influence of major histocompatibility complex-linked genes on the MOMP-specific antibody response in mice immunized with either whole GPIC elementary bodies or recombinant GPIC MOMP. Our results indicate that the MOMP-specific antibody response is major histocompatibility complex linked such that mice of the H-2d haplotype are high responders while mice of the H-2 haplotype are low responders. We demonstrate that MOMP-specific B cells are present in H-2k strains which are, however, deficient in MOMP-specific helper T cells. Although immunization of low-MOMPresponder strains with whole chlamydial elementary bodies induces high levels of immunoglobulin G antibody specific for Omp2, the cysteine-rich outer membrane protein, MOMP-specific B cells are unable to receive help from Omp2-specific T cells. The failure of intermolecular help from Omp2-specific T cells and related observations raise important issues regarding the processing and presentation of chlamydial antigens and the design of optimal subunit vaccines.
Chlamydiae are obligate intracellular pathogens causing ocular and genital tract diseases which affect as many as one billion people worldwide (12) . In developed countries, Chlamydia trachomatis is one of the major causes of sexually transmitted diseases, which in females can lead to infertility or ectopic pregnancy (37) . C. trachomatis can also give rise to trachoma, a disease which is endemic to a number of developing countries, and which is the principal cause of preventable blindness in the world (16) . A vaccine that could provide protection from Chlamydia infections would offer an effective means of controlling these diseases.
Genetic factors which can influence the host response to chlamydiae are important considerations in vaccine design.
Strains of mice that are susceptible or resistant to Chlamydiainduced pathology have been described, using salpingitis (36) , toxicity (10, 18) , and pneumonitis (19) models. These models indicate that resistance to chlamydial disease in mice is under the genetic control of at least one autosomal locus. Resistance to disease in these models does not appear to be linked to genes of the major histocompatibility complex (MHC). Other evidence, however, suggests that the immune response to various chlamydial components is under the influence of H-2-linked genes. Zhong and Brunham have reported that the antibody responses to C. trachomatis heat shock proteins Hsp6O and Hsp7O are MHC linked (41) . This may be impor-tant, since it has been suggested that the 57-kDa protein (the Hsp6O homolog) plays a role in eliciting the immunopathologies which are a decisive factor in chlamydial disease manifestations (25, 26) .
Current approaches to vaccine development are focused on the major outer membrane protein (MOMP) of chlamydiae. MOMP is thought to play a critical role in protective immunity, since this protein contains determinants which elicit serovarspecific neutralizing antibodies (40) . In addition, Batteiger et al. have demonstrated that immunization of guinea pigs with MOMP provides partial protective immunity against subsequent genital tract infection with Chlamydia psittaci strain guinea pig inclusion conjunctivitis (GPIC) (7) . GPIC is a natural pathogen of the guinea pig which can cause both ocular and genital tract infections. Since these infections closely resemble the ocular and genital tract infections caused by C. trachomatis in humans (5, 27, 30) , this system provides a useful animal model. We have investigated the role of MHC-linked genes in regulating the MOMP-specific antibody response of mice immunized with either whole GPIC elementary bodies (EBs) or recombinant MOMP (rMOMP). Our 75-cm2 L929 cell monolayers in the presence of cycloheximide (1 p,g/ml) (6) . EBs were purified and stored according to established procedures (28) . Except where indicated (legend to Fig.  9 ), viable EBs were used for all immunizations.
Recombinant proteins. Plasmid constructs used to express rMOMP and recombinant Omp2 (rOmp2) were generated by using the pTrcHisA expression vector (Invitrogen, San Diego, Calif.). The plasmid used to express rMOMP was generated by isolating the 1.1-kb BamHI-SalI DNA fragment of pPB1O (14) containing the region encoding mature GPIC MOMP. This fragment was then ligated into BamHI-XhoI-digested pTrcHisA followed by transformation into Escherichia coli JM109. The resulting fusion protein contains the vectorencoded histidine tag at the amino terminus of the mature MOMP sequence. Chimeras containing the appropriate insert size were screened by immunoblotting (9) for isopropylthio-o-D-galactoside (IPTG)-inducible expression of rMOMP, using a mouse monoclonal antibody specific for GPIC MOMP. An rMOMP-expressing plasmid designated pCD100 was used for subsequent rMOMP expression.
The pTrcHisA vector was also used to express rOmp2. The omp2 gene was amplified by PCR with primers based on the DNA sequence of the C. psittaci strain GPIC omp2 gene (20) . The primer for the 5' end of the gene was 5'-TITGGATC CGGGAAGATAGAGGCCG-3' incorporating a BamHI site.
The primer used for the 3' end of the gene was 5'-T'lTGTC GACT'TAATAAACATGTGTG-3' incorporating a Sall site. A recombinant plasmid containing the full-length genomic omp2 was used as a template for amplification, and the resulting product was ligated into the pTrcHisA vector as described above. Recombinants carrying the omp2 gene insert were screened by immunoblotting (9) for the ability to produce rOmp2 after induction with IPTG, using a polyclonal rabbit serum specific for GPIC Omp2. A chimeric plasmid expressing rOmp2 designated pCD200 was used in subsequent expression experiments.
Plasmid constructs used to express four MOMP fragments, each encoding one of the four variable domains (VDs), as fusions with E. coli maltose-binding protein (MBP) were generated by using the pMAL-c expression vector (New England Biolabs). Plasmid pPB10, encoding mature GPIC MOMP as a fusion with MBP, was prepared as described by Dascher et al. (14) . Fragments of the gene encoding MOMP (ompl) were generated by PCR amplification using pPB1O plasmid DNA as a template (31) . Oligonucleotide primers were designed so that the amplified ompl fragments have 5' EcoRI and 3' Sall restriction enzyme sites to allow for directional cloning into the pMAL expression vector. In addition, the primers ensure that the ompl gene fragments are in frame with the malE gene that encodes MBP. The 5' and 3' primers for each of the VDs are as follows: VD1, -5' primer I (5'-TTA-GAA-TTC-TTG-CCT-GTA-GGG-AAT-CC-3') and   3' primer III (5'-GCA-GTC-GAC-ATC-AAA-ACG-ATC-C  CA-3'); VD2, 5' primer II (5'-TTA-GAA-TTC-TGG-GAT-C  GT-TlTT-GAT-GT-3') and 3' primer V (5'-TTG-GTC-GAC-CAC-ATT-CCC-ATA-AAG-CT-3'); VD3, 5' primer IV (5'-GCG-GAA-ITC-GCT-TfA-TGG-GAA-TGT-GG-3') and 3'  primer VI (5'-CGC-GTC-GAC-TAT-AAG-AAA-GAG-CTA -AAC-3'); and VD4, 5' primer VII (5'-CGC-GAA-TTC-GGT -TTA-GCT-CTT-TCT-TA-3') and 3' primer VIII (5'-ACT-G TC-GAC-TTA-GAA-TCT-GAA-TTG-AGC-3'). PCR products were purified by using low-melting-point agarose gels, digested with EcoRI and Sall, cloned into pMAL-c, and transformed into E. coli DH5a. The C3D2F1/J mice were obtained from the Jackson Laboratory (Bar Harbor, Maine). BALB.K mice were bred at the University of Rochester (Rochester, N.Y.), and both males and females were used. Immunization of mice. All primary immunizations were administered subcutaneously at the base of the tail in complete Freund's adjuvant (CFA). All secondary immunizations were administered subcutaneously in the abdomen in incomplete Freund's adjuvant (IFA) 13 to 14 days after the primary immunization. Mice receiving either affinity-purified rMOMP (50 ,ug), live purified EBs (15 to 30 ,ug), or PBS for both the primary and secondary immunizations were bled from the orbital sinus 8 days after the secondary immunization. BALB/c mice used in the anamnestic experiments were primed with either affinity-purified rMOMP (50 ,ug), affinity-purified rOmp2 (50 ,ug), or PBS and then boosted with heat-inactivated EBs (50 ,ug) as previously described by Allen et al. (1) . Mice were bled from the orbital sinus 14 days after the secondary immunization. Serum was prepared and stored at -20°C until use (13) . Immunized mice whose spleens were to be cultured in vitro in the presence or absence of LPS received one immunization of EBs (30 ,ig) or affinity-purified rMOMP (50 ,ug) in CFA subcutaneously at the base of the tail. For immunizations involving BALB/c and C3H/HeJ mice, 3 to 10 animals were used per group. All other groups contained three animals, except for the BALB.K mice receiving EBs, in which case two animals were used per experimental group.
Generation of culture supernatants from T-cell-depleted spleen populations. Spleens were collected from naive and EBor rMOMP-immunized BALB/c and C3H/HeJ mice. Spleen cell populations were depleted of T cells by treatment with anti-Thy 1 antibody (T24-40.7) and complement. The remaining cells were carried at 106 cells per ml in complete RPMI 1640 supplemented with 10 mM (final) N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), 1 mM L-glutamine, 50 U of penicillin per ml, 50 jig of streptomycin per ml, 5 x 10' M 2-mercaptoethanol and 10% fetal calf serum in T-25 flasks for 4 days at 37°C and 7% CO2 in the presence or absence of LPS (50 ,ug/ml) (Sigma L-6018). Viable cells were counted, and culture supernatants were harvested. Supernatants, when necessary, were concentrated by using polyethylene glycol (Sigma P-2139) (13) so that the volume of the supernatant corresponded to the secretion of 106 viable cells per ml.
SDS-PAGE and Western immunoblot analysis. Electrophoresis of preparative SDS-11% polyacrylamide gels of chlamydial EB antigens and affinity-purified rMOMP and rOmp2 proteins was performed under reducing conditions (23). The separated proteins were then electrophoretically transferred to nitrocellulose (0.45-,Im diameter; Schleicher & Schuell), cut into strips corresponding to individual lanes, air dried, and stored at 4°C until use in immunoblot analysis (9, 13) . PBS containing 1 mM EDTA, 0.1% Tween 20, and 2.5% nonfat dry milk (PET-M) was used as a blocking agent. Individual lanes were incubated overnight at room temperature in the appropriate primary antibody, diluted in PET-M where necessary: rabbit polyclonal serum (1:10,000), mouse monoclonal antibody and mouse sera (1:1,000), or culture supernatants (undiluted). Lanes were then washed twice in PBS containing 1 (Fig. 1A and B) and rOmp2 ( Fig. 1C and D) in whole bacterial lysates and the resulting affinity-purified products are shown on Coomassie-stained SDS-polyacrylamide gels (Fig. 1A and C) and immunoblots ( Fig. 1B and D) .
Antibody response to GPIC in mice of the H-2d and H-2k haplotypes. Striking differences in the antibody response to chlamydial protein antigens are seen when pooled sera from groups of inbred strains of mice immunized with live GPIC EBs are subjected to immunoblot analysis (Fig. 2) . The variety of chlamydial antigens eliciting an antibody response in each mouse strain is reflected in multiple bands detected on immunoblots of whole EB proteins ( Fig. 2A) (Fig. 2A, lanes 2 and 3) .
Among proteins of the whole EB, the Omp2 antigen and the chlamydial GroEL homolog comigrate as a 60-kDa band (8) .
Immunoblots of rOmp2 were used to confirm that the pools of _ sera from each strain of EB-immunized mice contained high levels of Omp2-specific antibodies (Fig. 2B) . The contribution of GroEL-specific antibodies to the 60-kDa band was not determined. The specificity of antibodies recognizing the 40-kDa antigen in the EB immunoblots was confirmed on immunoblots of rMOMP (Fig. 2C) . In both the EB and rMOMP immunoblots, only the pooled sera from the EB-immunized H-2d mice react strongly with the MOMP antigen ( Fig. 2A and  C, lanes 1) . Little or no MOMP-specific antibody was detected in the pooled sera of the EB-immunized (H-2f) mice (BALB.K rMOMP and and C3H/HeJ) ( Fig. 2A and C, lanes 2 and 3) .
The levels of MOMP-and Omp2-specific antibodies in the d rMOMP (22 sera of the three strains of EB-immunized mice were quantinels C and D, tated by using rMOMP or rOmp2 proteins in a slot blot md the resultimmunoassay (Fig. 3) . This analysis confirmed the qualitative A and C) or observations made from the Western immunoblots shown in e monoclonal Fig. 2 . Immunization with EBs elicit high levels of Omp2-ilyclonal antispecific antibodies in all three strains of mice (Fig. 3A) . The BALB/c (H-2d) mice also have high levels of MOMP-specific antibodies, while each of the H-f mouse strains produces relatively low levels of MOMP-specific antibodies (Fig. 3B ). igens having
To determine whether the low-MOMP-responder phenola ( Fig. 2A) .
type is a dominant trait, the level of MOMP-specific antibodies antigen with in pooled sera of EB-immunized (H-2 x H-A)F1 hybrid mice, The presence of MOMP-specific antibodies in pools of sera from each strain of rMOMP-immunized mice was assessed by immunoblot analysis using whole EBs (Fig. 4) . Reactivity with the 40-kDa MOMP band on the EB immunoblots demonstrated the presence of MOMP-specific antibodies in the serum pools from the rMOMP-immunized H-2d strains, 2 3 BALB/c and DBA/2J (Fig. 4, lanes 1 and 2) , and an absence or )nse of GPIC very low levels of MOMP-specific antibodies in the serum ffinity-purified pools from the rMOMP-immunized H-2k strains, BALB.K and 5E separation C3H/HeJ (Fig. 4, lanes 3 and 4) . ing individual MOMP-specific antibody present in each pool of sera from nized BALB/c the strains of rMOMP-immunized mice was quantitated in a (H-2) (lanes slot blot immunoassay utilizing whole cell lysates of EBs to rum pool was detect the MOMP-specific antibody component (Fig. 5) . The ,era from the 3 . MOMP-and Omp2-specific antibody levels in the sera of EB-immunized mice. Pools of sera from EB-immunized BALB/c (H-2"), BALB.K (H-2k), and C3H/HeJ (H-2k) mice were used to probe serial dilutions of either affinity-purified rOmp2 (A) or rMOMP (B) spotted onto nitrocellulose, and the resulting autoradiograms were subjected to densitometric scanning as described in Materials and Methods. All sera were used at a 1:1,000 dilution. Pools of sera used in this experiment are described in legend to Fig. 2 . Lack of rOmp2 and rMOMP antibody in sera from preimmune and PBS-immunized mice was confirmed by immunoblot analysis (data not shown). The relative activity of the different sera can be determined from the slope of the absorbance curve in the region of linear response. The relative Omp2-specific binding activities of BALB.K and C3H sera were, respectively, 1.72 and 0.78 times that of BALB/c. In contrast, relative MOMP-specific binding activities of BALB.K and C3H sera were consistently less than 0.1 times that of BALB/c. the H-?2 strains (C3HIHeJ and BALB.K) are no greater than those of the negative control sera and are significantly lower than the MOMP-specific antibody levels seen in either of the two H-2" strains ( All sera were used at a 1:1,000 dilution and represent pools from 3 to 10 mice. The position of the MOMP band is indicated. the C. trachomatis serovars indicates that MOMP contains four regions of amino acid sequence hypervariability interspersed among five domains of conserved amino acid sequence (4, 11, 32, 38) . GPIC MOMP has a similar structure, and its conserved domains are highly homologous to those of C. trachomatis MOMP (39) . It has been previously reported that the immunodominant C. trachomatis MOMP-specific antibody response is directed at determinants within VD1 and VD4 (1, 34, 42) . To determine whether the homologous domains are also immunodominant in GPIC MOMP, four MOMP gene fragments were expressed as fusions with E. coli MBP by using the pMAL expression vector system. This expression vector system was used because it offers the potential for a high level of expres- sion of the cloned sequences (3, 17) and because it provides a one-step affinity purification by maltose affinity column chromatography (22) . Each of the resulting MBP-MOMP recombinants encodes one of the four VDs (Fig. 6A) . Western immunoblots of these MBP-MOMP recombinants were used to analyze pooled antisera from EB-immunized BALB/c (Fig.  6B ) and rMOMP-immunized DBA/2J mice (Fig. 6C) . Both pools of antisera recognize MOMP determinants expressed by the recombinant proteins encoding VD1 and VD4 (Fig. 6B and  C, lanes 3 and 6) . These results indicate that there are both structural and functional similarities between GPIC MOMP and C. trachomatis MOMP.
Analysis of MOMP-specific B cells in a low-MOMP-responder mouse -strain. Having determined that H-2k is a low-responder haplotype for MOMP-specific antibody responses, it was important to determine whether the lowresponder phenotype is due to a lack of MOMP-specific B cells in the H-2k mice relative to the H-2", high-MOMP-responder mice. To address this issue, we analyzed the GPIC proteinspecific antibodies produced by splenic B cells from both naive H-2k and naive H-2" mice following in vitro stimulation with the B-cell mitogen LPS. The LPS-responsive low-MOMPresponder C3H/HeSnJ (H-2k) mouse strain (35) was compared with the high-responder BALB/c (H-2d) mouse strain in these experiments.
Analysis of culture supernatants from LPS-stimulated splenic B cells of naive mice by rMOMP immunoblot indicates that MOMP-specific B cells are well represented in the C3H/ HeSnJ mice (Fig. 7, lane 3) . In a concurrently run immunoblot, the C3H/HeSnJ culture supernatants failed to recognize rOmp2, indicating (i) that MOMP-specific B precursors are either more frequent or more readily activated by LPS than Omp2-specific B precursors and (ii) that the antibodies recognizing rMOMP are specific for MOMP and not for vectorencoded peptide determinants (data not shown). The failure of the low-MOMP-responder mice to produce MOMP-specific antibody in response to immunization with whole EBs or rMOMP is not due to a lack of MOMP-specific B cells, since the level of MOMP-specific antibody in the culture supernatants from the C3H/HeSnJ LPS-stimulated naive splenic B cells is greater than that found in the culture supernatants from the LPS-stimulated naive BALB/c mouse spleens. 11 and 12) . T-cell-depleted splenic cell populations were cultured in the presence (lanes 1, 3, 5, 7, 9, and 11) or absence (lanes 2, 4, 6, 8, 10 , and 12) of LPS (50 jig/ml) for 4 days.
For the immunoblots, rMOMP was subjected to SDS-PAGE separation and transferred onto nitrocellulose. Strips representing individual lanes were probed with undiluted culture supernatants pooled from three individual spleen cell cultures. As indicated in the legend to Fig.  2 , the low-MOMP-responder phenotype of C3H/HeSnJ mice is indistinguishable from that of LPS-hyporesponsive C3H/HeJ mice.
To determine whether immunization with MOMP resulted in tolerance of the MOMP-specific B cells in the low-MOMPresponder mice, we analyzed the GPIC protein-specific antibodies in the culture supernatants from LPS-stimulated splenic B-cell populations of BALB/c and C3H/HeSnJ mice that had been primed once in vivo with either EBs or rMOMP. As expected, the LPS-induced MOMP-specific antibody response of BALB/c mice was increased following immunization (Fig. 7,  lanes 1, 5, and 9 ). In contrast, the response of primed C3H/HeSnJ spleen cells was not significantly increased or decreased relative to LPS-stimulated culture supernatants from naive animals (Fig. 7, lanes 3, 7, and 11 ). These experiments suggest that the lack of MOMP-specific antibody in the EB-and rMOMP-immunized H-2k mice is not due either to the absence of MOMP-specific B precursors or to induction of antigen-specific tolerance of the MOMP-specific B cells in these animals.
MOMP-and Omp2-specific T-cell proliferation in BALB/c and C3HVHeJ mice immunized with EBs. Since T-cell help is required to support the predominantly IgG MOMP-specific antibody response, we also investigated the influence of H-2-linked genes on the MOMP-specific T-cell response. T-cell proliferation assays were carried out on lymph node populations depleted of nylon wool-adherent cells from BALB/c (H-2d) and C3H/HeJ (H-2k) mice immunized with EBs (Fig.  8) . Restimulation in vitro with rMOMP and rOmp2 was used to determine whether the population of GPIC protein-specific T cells from EB-immunized mice included subsets of T cells that recognize MOMP or Omp2. Both strains of mice clearly have T cells that proliferate in response to rOmp2 (Fig. 8A) . Stimulation indices are 11 and 13 times above background proliferation levels for T cells from the BALB/c and C3H/HeJ mice, respectively (Fig. 8A) . In contrast, only the T cells from the BALB/c mice proliferate in response to rMOMP (Fig. 8B) . The T cells from the C3H/HeJ mice proliferate at levels that are at best only two times background levels in response to rMOMP (Fig. 8B) . The EB-immunized BALB/c and C3H/HeJ mice used in this experiment are the same animals whose sera were analyzed in Fig. 2 and 3 . Similar results have been obtained in three independent experiments.
MOMP-specific T cells provide intermolecular help for Omp2-specific B cells. Since MOMP and Omp2 are both present in the EB outer membrane, it would, in principle, be possible for Omp2-specific helper T cells to support the production of MOMP-specific antibody in response to EB immunization. This is, however, clearly not the case in EBimmunized C3H/HeJ mice. Such mice have both MOMPspecific B cells (Fig. 7) and Omp2-specific T cells (Fig. 8A ) able to provide help for an Omp2-specific IgG antibody response ( Fig. 2A and B) . They are, nevertheless, unable to give rise to a MOMP-specific antibody response following immunization with whole EBs. Apparently, MOMP-specific B cells cannot receive help from Omp2-specific T cells in H-2k mice.
A. rOmp2 B. rMOMP Immunoblot analysis of the MOMP-and Omp2-specific anamnestic antibody responses of BALB/c mice. Affinity-purified rMOMP (A) and rOmp2 (B) were subjected to SDS-PAGE separation and transferred onto nitrocellulose. Strips representing individual lanes were reacted with pooled antisera from BALB/c mice that had been primed with rMOMP in CFA (lanes 1), rOmp2 in CFA (lanes 2), or PBS in CFA (lanes 3) and then boosted with nonviable EBs, prepared as described by Allen et al. (1) in IFA. Each pool of sera was derived from three animals, and all sera were used at a 1:1,000 dilution.
To further explore the conditions under which intermolecular help can be provided, we wished to determine whether the reciprocal relationship applies, that is, whether Omp2-specific B cells can receive help from MOMP-specific T cells. Since MOMP-specific T cells are absent in low-responder H-2 mice, this issue had to be addressed in a high-responder H-2d strain. MOMP-and Omp2-specific T cells were selectively stimulated by primary immunization of BALB/c (H-2") mice with recombinant proteins. The secretion of MOMP-and Omp2-specific antibodies elicited in response to secondary immunization with EBs was then analyzed on MOMP and Omp2 immunoblots. In this protocol, MOMP-and Omp2-specific antibody secretion is dependent on the T-cell help that is specifically stimulated by primary immunization with either rMOMP or rOmp2. A specific antibody response is not detected in a control group of BALB/c mice primed with PBS in CFA and boosted with EBs in IFA (Fig. 9, lanes 3 ).
Secondary immunization with whole EBs of Omp2-primed mice induces Omp2-specific antibody (Fig. 9B, lane 2) but not MOMP-specific antibody (Fig. 9A, lane 2) . This finding is consistent with the results obtained from the EB-immunized low-MOMP-responder H-2k mice (Fig. 2) and confirms that MOMP-specific B cells do not receive efficient help from Omp2-specific T cells. In contrast, immunoblot analysis of pooled sera from BALB/c mice primed with rMOMP and then boosted with EBs demonstrate antibody reactivity with both rMOMP (Fig. 9A, lane 1) and rOmp2 (Fig. 9B, lane 1) . These results suggest that Omp2-specific B cells do have the ability to take up either whole EBs or some form of a MOMP-Omp2 complex so that they are able to process and present MOMP determinants to helper T cells. MOMP-specific B cells, however, do not take up or do not process Omp2 determinants in similar complexes of GPIC MOMP and Omp2. As discussed below, there is precedent for determinant restricted intermolecular help also in the response to C. trachomatis MOMP.
The MOMP-specific response to C. trachomatis in humans and to C. psittaci in guinea pigs is highly variable. Since a MOMP-specific antibody response is thought to be important for induction of protective immunity (7, 40) , it is important to identify factors that govern this variability or that could overcome a low-responder status. Here, we demonstrate that the antibody response to C. psittaci GPIC MOMP is H-2 linked such that mice of the H-2d haplotype are high responders while mice of the H-2k haplotype are low responders. In addition, we describe the failure of Omp2-specific T cells to provide intermolecular help to support a GPIC MOMP-specific antibody response in both low-and high-MOMP-responder strains.
H-2-linked regulation of the MOMP-specific antibody response is evident whether the source of the MOMP immunogen is whole GPIC EBs (Fig. 2 and 3 ) or purified recombinant protein (Fig. 4 and 5) . Although unresponsive to MOMP, H-2k mice do mount vigorous specific antibody responses to other GPIC protein antigens, in particular Omp2 ( Fig. 2 and 3) . The low MOMP-specific antibody response of H-2k mice following immunization with EB or rMOMP is not due to a lack of MOMP-specific B cells, since significant levels of MOMPspecific antibodies are found in culture supernatants of LPSstimulated splenic B cells from naive C3H/HeSnJ (H-2k) mice (Fig. 7) . Furthermore, the failure of the EB-and rMOMPimmunized H-2k mice to produce MOMP-specific antibodies is not due to tolerization of MOMP-specific B cells, since high levels of MOMP-specific antibodies are also found in the culture supernatants of LPS-stimulated splenic B cells from immunized mice (Fig. 7) . Immunoblot analysis using a panel of MBP-MOMP recombinants that encode each of the individual variable domains demonstrates that the immunodominant MOMP-specific antibody response is directed at the VD1 and VD4 regions of MOMP (Fig. 6) . These are the same MOMP domains previously reported to encode the immunodominant MOMP-specific antibody specificities of various C. trachomatis serovars (1, 34, 42) and reflect the structural and functional homology between these different Chlamydia species.
Since the MOMP-specific IgG antibody response is dependent upon T-cell help, we also analyzed antigen-specific T-cell responses in BALB/c (H-2d) and C3H/HeJ (H-2k) mice immunized with EBs (Fig. 8) . Both mouse strains mount strong Chlamydia-specific T-cell responses, as indicated by high levels of specific T-cell proliferation in response to both live EBs (Fig. 8) and EBs inactivated by exposure to UV light (data not shown). Within these populations of T cells specific for EB protein antigens, both strains give rise to a significant Omp2-specific T-cell response (Fig. 8A) , but only the BALB/c (H-2d) T cells give a MOMP-specific proliferative response (Fig. 8B) .
Because MOMP and Omp2 are both present in the EB outer membrane, it is possible that a mechanism of intermolecular T-cell help is available to support the production of MOMPand/or Omp2-specific antibodies in response to EB immunization. However, since low-MOMP-responder mice have both MOMP-specific B cells (Fig. 7) and Omp2-specific T cells (Fig.  8A) , the lack of MOMP-specific antibodies in response to immunization with whole EBs (Fig. 2) with whole EBs was then assessed by using rMOMP and rOmp2 immunoblots. BALB/c mice primed with rMOMP produce both MOMP-and Omp2-specific antibodies in response to a boost with EBs (Fig. 9, lanes 1) . In contrast, Omp2-primed BALB/c mice give no detectable MOMP-specific antibody response to secondary immunization with EBs (Fig. 9A, lane 2) . This result confirms the conclusion from H-2k low-MOMP-responder mouse strains that Omp2-specific T cells are unable to provide help to MOMP-specific B cells. It further indicates that the relationship is not reciprocal in that MOMP-specific T cells do provide help for Omp2-specific B cells.
The results reported here differ somewhat from those previously reported by Allen and Stephens in an analysis of the immune response to C. trachomatis serovar B (2). These workers detected a mechanism of intermolecular T-cell help for both MOMP-and Omp2-specific B cells (2). In these experiments, mice were primed with glutathione S-transferase fusion proteins encoding fragments of either MOMP, Omp2, or Omp3. Following a secondary boost with nonviable EBs of C. trachomatis serovar B, mice in which MOMP-or Omp2-specific T cells were primed produced both MOMP-and Omp2-specific antibodies but not Omp3-specific antibodies. In contrast, mice in which Omp3-specific T cells were primed produced Omp3-specific antibodies but failed to produce either MOMP-or Omp2-specific antibodies. The authors concluded from these results that a mechanism of intermolecular T-cell help exists for MOMP-and Omp2-specific B cells. However, in the case of Omp3, helper T-cell determinants are apparently dissociated from the other target molecules, and consequently there is a failure to elicit intermolecular T-cell help. Careful examination of the data suggests, however, that there is a more subtle failure of intermolecular help for C. trachomatis serovar B MOMP-specific B cells. Priming with MOMP gives rise to approximately a 10-fold-greater MOMPspecific response to a secondary EB boost than does priming with Omp2. However, when antibody fine specificity is assayed, equal amounts of VD1-specific antibody are detected whether animals are primed with MOMP or Omp2. It appears, therefore, that intermolecular help is predominantly available for serovar B MOMP VD1-specific B cells but not for B cells specific for other serovar B MOMP determinants. Whatever the discriminatory mechanism (see below), it is apparent that sequence variation in the critical VD1 region may lead to a complete loss of intermolecular help for a MOMP-specific response as we have, indeed, observed for GPIC MOMP. With respect to the ability of Omp2-specific B cells to receive help from MOMP-specific T cells, results for C. trachomatis and C. psittaci are concordant.
There are a number of possible explanations for the unidirectional failure of Omp2-specific T cells to provide intermolecular T-cell help to MOMP-specific B cells although MOMPspecific T cells do provide help to Omp2-specific B cells. A simple explanation might have been that MOMP is more efficiently processed and presented in association with MHC than Omp2 and, therefore, that MOMP-specific T cells respond much more vigorously to challenge with whole EB particles than do Omp2-specific T cells. This is, however, unlikely since the magnitude of the Omp2-specific T-cell Alternatively, if MOMP-and Omp2-specific B cells both take up and process the same form of the antigen, that is, a MOMP-Omp2 complex, then the unidirectional failure of Omp2-specific T cells to provide help to MOMP-specific B cells must be explained by differential antigen processing in MOMP-and Omp2-specific B cells. It has been reported in several systems that the specificity of the B-cell immunoglobulin receptor can influence the processing and presentation of antigen such that some peptides are preferentially protected or degraded (15, 24, 29) . If the immunodominant Omp2 peptides that associate with class II MHC in H-2k and H-2d strains are relatively susceptible to degradation, then it may be that only when taken up through an Omp2-specific receptor are they sufficiently protected to associate with MHC for membrane expression and presentation to MOMP-specific T cells. This is somewhat more consistent with the implied failure of C. trachomatis Omp2-specific T cells to provide help to MOMP VD4-specific B cells although they clearly do provide help to MOMP VD1-specific B cells. For structural reasons, a B-cell receptor specific for the VD1 determinant of C. trachomatis serovar B MOMP might be more protective of neighboring Omp2 determinants than the receptors for either the VD4 determinant of C. trachomatis MOMP or the VD1 determinant of C. psittaci MOMP.
Our findings regarding the MHC linkage of the MOMPspecific antibody response and the failure of intermolecular T-cell help in low-MOMP-responder mouse strains raise issues that are of fundamental importance to the design of an optimal Chlamydia subunit vaccine. Although an MHC linkage for the antibody response to the C. trachomatis Hsp6O and Hsp7O proteins has been reported (41) , an influence of MHC on the antibody response to MOMP was not detected for the one C. trachomatis serovar in which this issue has been quantitatively analyzed (33) . Given the fine-specificity differences in the immunodominant variable regions of the 15 known C. trachomatis serovars, this does not permit any broader generalization. In view of the observed and unexplained variability of the MOMP-specific human humoral response (28) and the results reported here for an MHC-regulated response to the structurally and functionally homologous GPIC MOMP, selection of any vaccine candidate will require a more complete investigation of potential HLA-linked regulation of the MOMP-specific antibody response and evaluation of available intermolecular help for identified low-responder haplotypes.
